DRKS00006742已完成未知
Pilot study regarding the influence of bioactive enriched food on markers of the metabolic syndrome. - PATHWAY-27
Max Rubner-InstitutBundesforschungsinstitut für Ernährung und Lebensmittel0 个研究点目标入组 68 人开始时间: 2015年6月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 80 Years(—)
- 性别
- All
入选标准
- •MS is defined when three of the following criteria are met:
- •- elevated waist circumference (men = 102 cm; women = 88 cm)
- •- elevated fasting triglycerides (= 150 mg/dL)
- •- reduced fasting HDL-cholesterol (men = 40 mg/dL; women = 50 mg/dL)
- •- elevated blood pressure (systolic = 130 mmHg and/or diastolic = 85 mmHg) or
- •hypotensive treatment
- •- elevated fasting glucose (= 110 mg/dL)
- •Subjects will be eligible to the pilot study if they are considered at risk of MS, i.e. if they
- •present two to four of the MS criteria, at least one of them being alterated of fasting
- •triglycerides or HDL-Cholesterol”.
排除标准
- •Participants that meet more than four of the metabolic syndrome criteria; -regular drug therapy with impact on serum lipids (e.g. statins, fibrates, ...);
- •- diabetes (fasting glucose = 1.26 g/L, or anti-diabetic treatment);
- •- celiac disease, lactose intolerance, allergy to milk or egg proteins;
- •- antibiotic treatment within the last 3 months;
- •- recent history of cancer or cancer treatment (less than 2 years);
- •- active or recently diagnosed intestinal malabsorption;
- •- familial dyslipidemia;
- •- illegal drug use or chronic alcoholism or active smoking (= 5 cigarettes/day);
- •- intensive physical exercise (= 5 hour/week);
- •- consumption of nutritional supplements containing DHA, BG or AC;
- •- history of allergy or intolerance to any components used in BEFs;
- •institutionalised patients, those who lack autonomy to consent or are unable to meet all
- •examinations;
- •- women who are pregnant, lactating, on contraceptive treatment or hormone replacement
- •- participation in other clinical trials that may impact on outcome;
- •- subjects deprived of their liberty by judicial or administrative decision; -Participants that are expected to be non-compliant.
研究者
相似试验
已完成
不适用
Observational study on the therapeutic effect of endoscopic stent placement for malignant gastroduodenal obstructioMalignant gastroduodenal obstructionJPRN-UMIN000026193Kanazawa University Hospital Department of Gastroenterology200
已完成
不适用
A pilot study to evaluate safety and efficacy of electrohydraulic lithotripsy for difficult biliary and pancreatic stonesBiliary and pancreatic stonesJPRN-UMIN000013130Graduate School of Medicine, The University of Tokyo30
进行中(未招募)
1 期
Evaluation of the effect of a low-level laser in the surgical treatment of periodontal pocketsISRCTN13012199Damascus University10
已完成
1 期
Evaluation of efficacy and safety of Ebola vaccine iEvac-Z in humaJPRN-jRCTs031190118Koga Michiko30
招募中
不适用
Prospective study of the exploration of bioactive lipid biomarker involved in ocular diseasesJPRN-UMIN000027137The University of Tokyo500
